FAYEZ SAROFIM & CO – Regeneron Pharmaceuticals, Inc. Transaction History
FAYEZ SAROFIM & CO portfolio value:
$1.61M
portfolio value
FAYEZ SAROFIM & CO quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 230K | $688.87 | 2.35K | |
| Q2 2022 | share | Increase | +2.17% | 50 shares | -217K | $591.13 | 2.35K |
| Q1 2022 | share | Increase | +27.78% | 500 shares | 469K | $698.42 | 2.3K |
| Q4 2021 | share | Increase | +260.00% | 1.3K shares | 834K | $642.51 | 1.8K |
| Q3 2021 | share | 0.00% | 0 shares | 24K | $605.18 | 500 | |
| Q2 2021 | share | Decrease | -37.50% | -300 shares | -100K | $558.54 | 500 |
| Q1 2021 | share | Decrease | -32.38% | -383 shares | -193K | $473.14 | 800 |
| Q4 2020 | share | Increase | +11.81% | 125 shares | -20K | $483.11 | 1.18K |
| Q3 2020 | share | 0.00% | 0 shares | -68K | $559.78 | 1.05K | |
| Q2 2020 | share | 0.00% | 0 shares | 143K | $623.65 | 1.05K | |
| Q1 2020 | share | Decrease | -8.64% | -100 shares | 82K | $488.29 | 1.05K |
| Q4 2019 | share | 0.00% | 0 shares | 114K | $375.48 | 1.15K | |
| Q3 2019 | share | 0.00% | 0 shares | -41K | $277.4 | 1.15K | |
| Q2 2019 | share | 0.00% | 0 shares | -113K | $313 | 1.15K | |
| Q1 2019 | share | Increase | +18.77% | 183 shares | 111K | $410.62 | 1.15K |
| Q4 2018 | share | Increase | +18.18% | 150 shares | 31K | $373.5 | 975 |
| Q3 2018 | share | 0.00% | 0 shares | 48K | $404.04 | 825 | |
| Q2 2018 | share | Decrease | -5.28% | -46 shares | -15K | $344.99 | 825 |
| Q1 2018 | share | Decrease | -4.18% | -38 shares | -42K | $344.36 | 871 |
| Q4 2017 | share | Increase | +5.33% | 46 shares | -44K | $375.96 | 909 |
| Q3 2017 | share | 0.00% | 0 shares | -38K | $447.12 | 863 | |
| Q2 2017 | share | 0.00% | 0 shares | 90K | $491.14 | 863 | |
| Q1 2017 | share | Increase | 0.00% | 863 shares | 334K | $387.51 | 863 |